Zalika
We provide an integrated solution to enable the assertive entry strategy of advanced and affordable medicines, medical devices, dermo-cosmetics and health products into the brazilian life sciences market.
Your Entry into the Brazilian Market
If your company is considering the insertion of your portfolio and pipeline of products in the high potential Life Sciences Market represented by the Brazilian Country, Zalika Farmacêutica must be your local partner in Brazil!
Conceiving tailored projects, Zalika will support your company in all stages of the Market Entry Strategy.
Adar Poonawalla ‘delighted’ over Oxford-AstraZeneca-Serum vaccine’s efficacy
Serum Institute of India CEO Adar Poonawalla expressed joy on Twitter after Oxford University announced that the Oxford-Astrazeneca COVID-19 vaccine candidate, is up to 90% effective in preventing COVID-19 infection. Serum Institute of India, which is the world’s largest manufacturer of vaccines by volume, has partnered with AstraZeneca to mass-produce the COVID-19 vaccine. Poonawalla tweeted,… See more »
Pfizer to invest €300 million in Irish operations
Pfizer has announced that it is set to make an approximately €300 million capital investment in its Irish operations to support the further development of existing manufacturing sites in Grange Castle, Newbridge and Ringaskiddy. The investment will provide additional manufacturing and laboratory capacity creating approximately 300 roles, with additional anticipated construction roles in Ringaskiddy, Cork…. See more »